Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa

Background. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Razia A. G. Khammissa, Liron Pantanowitz, Liviu Feller
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2012/873171
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551296403505152
author Razia A. G. Khammissa
Liron Pantanowitz
Liviu Feller
author_facet Razia A. G. Khammissa
Liron Pantanowitz
Liviu Feller
author_sort Razia A. G. Khammissa
collection DOAJ
description Background. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods. All cases with confirmed oral HIV-KS treated at the oral medicine clinic in Ga-Rankuwa from 2004 to 2010 were included in this retrospective study. Differences between males and females with oral HIV-KS in relation to HIV infection status, to oral KS presentation and to survival rates were statistically analysed. Results. Twenty (54%) of the 37 patients in the study were females and 17 (46%) were males. In 21 patients (57%), the initial presentation of HIV-KS was in the mouth. Other than the fact that females presented with larger (≥10 mm) oral KS lesions (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.0003). Nine patients (24%) developed concomitant facial lymphoedema, and these patients had a significantly lower CD4+ T-cell count (28 cells/mm3) compared to the rest of the group (130 cells/mm3) (P=0.01). The average CD4+ T-cell count of the patients who died (64 cells/mm3) was significantly lower (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.016) at the time of oral-KS presentation than of those who survived (166  cells/mm3). Conclusions: In Ga-Rankuwa, South Africa where HIV-KS is prevalent, oral KS affects similarly males and females. A low CD4+ T-cell count at the time of oral HIV-KS diagnosis and the development of facial lymphoedema during the course of HIV-KS disease portends a poor prognosis.
format Article
id doaj-art-f87bc11f9e814f68a055572cc779db3b
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-f87bc11f9e814f68a055572cc779db3b2025-02-03T06:01:50ZengWileyAIDS Research and Treatment2090-12402090-12592012-01-01201210.1155/2012/873171873171Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South AfricaRazia A. G. Khammissa0Liron Pantanowitz1Liviu Feller2Department of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, Pretoria 0204, South AfricaDepartment of Pathology, University of Pittsburgh Medical Centre, Pittsburgh, PA 15260, USADepartment of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, Pretoria 0204, South AfricaBackground. Kaposi sarcoma (KS) is one of the most common neoplasms diagnosed in HIV-seropositive subjects. Oral involvement is frequent and is associated with a poor prognosis. The aim of this study was to characterize the features of oral HIV-KS in patients from Ga-Rankuwa, South Africa. Methods. All cases with confirmed oral HIV-KS treated at the oral medicine clinic in Ga-Rankuwa from 2004 to 2010 were included in this retrospective study. Differences between males and females with oral HIV-KS in relation to HIV infection status, to oral KS presentation and to survival rates were statistically analysed. Results. Twenty (54%) of the 37 patients in the study were females and 17 (46%) were males. In 21 patients (57%), the initial presentation of HIV-KS was in the mouth. Other than the fact that females presented with larger (≥10 mm) oral KS lesions (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.0003). Nine patients (24%) developed concomitant facial lymphoedema, and these patients had a significantly lower CD4+ T-cell count (28 cells/mm3) compared to the rest of the group (130 cells/mm3) (P=0.01). The average CD4+ T-cell count of the patients who died (64 cells/mm3) was significantly lower (P=0.0004), there were no statistically significant gender differences. Significantly more patients presented with multiple oral HIV-KS lesions than with single lesions (P=0.016) at the time of oral-KS presentation than of those who survived (166  cells/mm3). Conclusions: In Ga-Rankuwa, South Africa where HIV-KS is prevalent, oral KS affects similarly males and females. A low CD4+ T-cell count at the time of oral HIV-KS diagnosis and the development of facial lymphoedema during the course of HIV-KS disease portends a poor prognosis.http://dx.doi.org/10.1155/2012/873171
spellingShingle Razia A. G. Khammissa
Liron Pantanowitz
Liviu Feller
Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
AIDS Research and Treatment
title Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
title_full Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
title_fullStr Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
title_full_unstemmed Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
title_short Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa
title_sort oral hiv associated kaposi sarcoma a clinical study from the ga rankuwa area south africa
url http://dx.doi.org/10.1155/2012/873171
work_keys_str_mv AT raziaagkhammissa oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica
AT lironpantanowitz oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica
AT liviufeller oralhivassociatedkaposisarcomaaclinicalstudyfromthegarankuwaareasouthafrica